WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 4 fonti

Novo Nordisk launches weekly insulin shot Awiqli in India

Novo Nordisk launches Awiqli, the world's first once-weekly insulin, in India to revolutionize diabetes management.

Raccontata daeconomictimes.indiatimes.comthehindubusinessline.comhindustantimes.comthehindu.com

Confronto fonti

4 prospettive sulla stessa storia
AI · summaries
thehindu.comStai leggendo1 g fa

Novo Nordisk launches weekly insulin shot Awiqli in India

Novo Nordisk launches Awiqli, the world's first once-weekly insulin, in India to revolutionize diabetes management.

originale
economictimes.indiatimes.com1 g fa

Novo Nordisk launches once-weekly basal insulin 'Awiqli' in India as diabetes rates increase

Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to daily injections for diabetes patients. Awiqli aims to reduce barriers to…

Leggi questa versione → originale
hindustantimes.com1 g fa

India gets Novo Nordisk's once-weekly insulin injection Awiqli for adults with diabetes

The injection replaces the need for a daily basal insulin injection with a once-a-week dose. This reduces the annual number of injections from 365 to just 52. | India News

Leggi questa versione → originale
thehindubusinessline.com1 g fa

Novo Nordisk India rolls-out a once-weekly basal insulin Awiqli

The product will be imported from Denmark and is priced at ₹2611 for a 1 ml pen (700 insulin units)

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 8 luglio 2026·economictimes.indiatimes.com

    Novo Nordisk readies once-a-week insulin shot for Indian market

    Novo Nordisk is set to introduce Awiqli, an innovative once-weekly insulin, in India shortly. This remarkable treatment drastically cuts down the number of insulin injections from…

  2. giovedì 9 luglio 2026·economictimes.indiatimes.com

    Novo Nordisk launches once-weekly basal insulin 'Awiqli' in India as diabetes rates increase

    Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to daily injections for diabetes patients.…

  3. giovedì 9 luglio 2026·thehindubusinessline.com

    Novo Nordisk India rolls-out a once-weekly basal insulin Awiqli

    The product will be imported from Denmark and is priced at ₹2611 for a 1 ml pen (700 insulin units)

  4. giovedì 9 luglio 2026·hindustantimes.com

    India gets Novo Nordisk's once-weekly insulin injection Awiqli for adults with diabetes

    The injection replaces the need for a daily basal insulin injection with a once-a-week dose. This reduces the annual number of injections from 365 to just 52. | India News

  5. giovedì 9 luglio 2026·thehindu.com

    Novo Nordisk launches weekly insulin shot Awiqli in India

    Novo Nordisk launches Awiqli, the world's first once-weekly insulin, in India to revolutionize diabetes management.

  6. venerdì 10 luglio 2026·hindustantimes.com

    World’s first once-weekly insulin injection launched in India: Endocrinologist shares 7 things to know before switching

    Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side effects, and dosage. | Health

  7. venerdì 10 luglio 2026·economictimes.indiatimes.com

    Once-a-week insulin launched in India, but doctors say it won't replace daily shots for all

    India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 to just 52 for many individuals. Experts suggest…